| Protein Coverage | Supporting Peptides |
Protein Coverage:
Supporting Peptides:
Peptide Candidates Quality Significance (-10lgP) m/z RT range z Avg. Area Sample Profile Group Profile RT mean Start End Used PTM
K.HVVFGK.I 2.81 0.11 343.7058 33.09 - 41.98 2 5.2E5 35.72 168 173 N
Q.TPWLDGK.H 2.75 0.02 408.7199 58.59 - 66.56 2 3E5 61.81 161 167 N
K.GFGYK.G 2.11 0.38 571.2916 35.89 - 44.84 1 2.5E5 38.69 85 89 N
K.TAENFIALATGEK.G Y 3.24 3.39 682.8595 105.71 - 110.14 2 2.1E5 107.51 72 84 Y
R.IVIGVFGK.T Y 3.67 4.19 416.7707 92.57 - 97.35 2 2.1E5 94.67 60 67 Y
K.ILEGMDVVK.K Y 2.62 1.15 502.2812 75.25 - 80.36 2 1.8E5 77.20 174 182 Y
K.DFMIQGGDFTR.G Y 2.56 0.92 643.7988 93.76 - 97.62 2 1.4E5 95.26 99 109 N
K.IDVDQPFAVPK.E Y 2.64 1.31 614.8357 89.52 - 93.18 2 1.4E5 90.95 207 217 N
K.VFFDMK.V Y 2.68 1.63 393.6985 84.14 - 89.40 2 1.1E5 86.28 46 51 N
K.SIYGDRFPDENFK.L Y 2.46 1.80 529.9229 75.46 - 81.46 3 9.2E4 78.26 119 131 N
R.FPDENFK.L 1.58 0.91 448.7196 52.51 - 61.68 2 7.9E4 57.18 125 131 N
K.H(+43.01)VVFGK.I 1.62 0.26 365.2086 45.51 - 54.75 2 7.5E4 48.64 168 173 N Carbamylation
F.ITTIQTPWLDGK.H Y 2.80 2.44 686.8810 102.47 - 106.50 2 6.9E4 104.32 156 167 N
K.HYAPGWLSMANAGK.D Y 1.72 0.31 501.5813 83.27 - 89.21 3 6.7E4 85.89 134 147 N
K.HVVFGK.I 1.93 0.84 686.4029 33.15 - 41.41 1 5.4E4 35.72 168 173 N
R.VIKDFMIQGGDFTR.G Y 2.03 4.01 542.9511 93.24 - 97.93 3 5.1E4 95.47 96 109 N
Q.TPWLDGK.H 0.12 5.98 408.7073 57.87 - 62.71 2 4.4E4 60.72 161 167 N
K.HYAPGWLSMANAGK.D Y 0.93 0.13 751.8663 83.00 - 89.34 2 3.9E4 85.77 134 147 N
Q.TPWLDGK.H 2.12 3.65 816.4292 58.59 - 66.69 1 3.7E4 61.73 161 167 N
K.SIYGDRFPDENFK.L Y 1.30 1.23 794.3789 76.09 - 79.90 2 2.7E4 78.06 119 131 N
K.DVVIHDCGK.I Y 1.08 1.48 493.2447 35.19 - 44.80 2 2.6E4 38.33 198 206 N
K.TAENFIALATGEK.G Y 2.42 2.20 455.5758 105.71 - 109.68 3 2.5E4 107.52 72 84 N
K.IDVDQPFAVPKE Y 0.16 1.32 679.3582 90.48 - 92.34 2 2E4 91.45 207 218 N
K.G(+43.01)FGYK.G 0.25 0.19 614.2962 48.55 - 53.70 1 1.8E4 50.73 85 89 N Carbamylation
R.IVIGVFGK.T Y 2.34 2.15 832.5328 92.64 - 97.22 1 1.6E4 94.67 60 67 N
K.H(+43.01)YAPGWLSMANAGK.D Y 0.90 0.36 773.3705 101.64 - 105.36 2 1.5E4 103.20 134 147 N Carbamylation
K.VFFDMK.V Y 0.81 1.10 786.3908 83.82 - 88.21 1 1.4E4 86.15 46 51 N
K.DTNGSQFFITTIQTPWLDGK.H Y 1.58 1.51 757.0492 133.34 - 134.14 3 1.3E4 133.78 148 167 N
Q.T(+43.01)PWLDGK.H 1.23 2.87 859.4360 85.91 - 90.57 1 1.2E4 88.06 161 167 N Carbamylation
F.FITTIQTPWLDGK.H Y 1.04 0.44 760.4145 122.52 - 125.38 2 9.6E3 123.96 155 167 N
R.DKPLKDVVIHDCGK.I Y 0.20 2.65 392.4657 48.58 - 53.25 4 8.8E3 51.33 193 206 N
R.VIKDFMIQGGDFTR.G Y 0.63 3.20 813.9183 91.46 - 97.60 2 7.1E3 95.62 96 109 N
K.DTNGSQFFITTIQTPWLDGK.H Y 1.27 0.41 1135.0668 133.25 - 134.54 2 5.8E3 133.77 148 167 N
R.DKPLKDVVIHDCGK.I Y 0.18 6.42 522.9542 48.82 - 52.35 3 5.6E3 50.60 193 206 N
Q.T(+43.01)PWLDGK.H 0.42 1.70 430.2215 86.16 - 90.21 2 5.5E3 87.92 161 167 N Carbamylation
K.GFGYK.G 0.15 1.34 571.2740 35.16 - 45.60 1 5.3E3 38.43 85 89 N
R.FPDENFK.L 0.02 5.30 448.7179 55.24 - 60.24 2 4.5E3 58.34 125 131 N
K.T(+43.01)AENFIALATGEK.G Y 0.55 0.87 704.3642 131.22 - 132.21 2 3.8E3 131.60 72 84 N Carbamylation
K.ILEGMDVVKK.I Y 0.01 1.91 377.8838 62.16 - 63.29 3 3.5E3 62.50 174 183 N
K.IDVDQPFAVPKE Y 0.00 2.73 679.3660 90.90 - 92.80 2 3.4E3 91.49 207 218 N
K.TAENFIALATGEK.G Y 1.49 1.25 1364.7077 105.67 - 109.48 1 1.9E3 107.53 72 84 N
R.DKPLKDVVIHDC(+57.02)GK.I Y 0.02 2.29 541.9611 42.53 - 45.24 3 1.5E3 43.96 193 206 N Carbamidomethylation
K.ILEGMDVVK.K Y 0.00 1.33 502.2800 74.21 - 78.49 2 1.5E3 75.95 174 182 N
K.DTNGSQFFITTIQT(-18.01)PWLDGK.H Y 0.18 0.25 751.0472 133.74 - 134.33 3 1.4E3 133.94 148 167 N Phospho neutral loss (ST)
K.T(+43.01)AENFIALATGEK.G Y 0.07 1.10 704.3642 131.20 - 132.31 2 1.2E3 131.78 72 84 N Carbamylation
Q.TPWLDGK.H 0.00 5.26 816.4126 60.41 - 65.13 1 1.1E3 62.82 161 167 N
total 46 peptides